0001410442-23-000004.txt : 20230615 0001410442-23-000004.hdr.sgml : 20230615 20230615102258 ACCESSION NUMBER: 0001410442-23-000004 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230614 FILED AS OF DATE: 20230615 DATE AS OF CHANGE: 20230615 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Jain Vivek CENTRAL INDEX KEY: 0001410442 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34634 FILM NUMBER: 231016237 MAIL ADDRESS: STREET 1: ICU MEDICAL, INC. STREET 2: 951 CALLE AMANECER CITY: SAN CLEMENTE STATE: CA ZIP: 92673 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ICU MEDICAL INC/DE CENTRAL INDEX KEY: 0000883984 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 330022692 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 951 CALLE AMANECER CITY: SAN CLEMENTE STATE: CA ZIP: 92763-6212 BUSINESS PHONE: 949-366-2183 MAIL ADDRESS: STREET 1: 951 CALLE AMANECER CITY: SAN CLEMENTE STATE: CA ZIP: 92763-6212 4 1 edgardoc.xml PRIMARY DOCUMENT X0407 4 2023-06-14 0 0000883984 ICU MEDICAL INC/DE ICUI 0001410442 Jain Vivek 951 CALLE AMANECER SAN CLEMENTE CA 92673 1 1 0 0 Chairman and CEO 1 Common Stock 2023-06-14 4 M 0 6712 58.79 A 30389 D Common Stock 2023-06-14 4 S 0 6712 185.7305 D 23677 D Common Stock 2023-06-14 4 M 0 3637 58.79 A 27314 D Common Stock 2023-06-14 4 S 0 3637 186.5029 D 23677 D Common Stock 2023-06-14 4 M 0 2781 58.79 A 26458 D Common Stock 2023-06-14 4 S 0 2781 187.434 D 23677 D Common Stock 2023-06-14 4 M 0 8163 58.79 A 31840 D Common Stock 2023-06-14 4 S 0 8163 188.5155 D 23677 D Common Stock 2023-06-14 4 M 0 785 58.79 A 24462 D Common Stock 2023-06-14 4 S 0 785 189.3167 D 23677 D Common Stock 2023-06-14 4 M 0 1699 58.79 A 25376 D Common Stock 2023-06-14 4 S 0 1699 190.482 D 23677 D Common Stock 2023-06-14 4 M 0 1601 58.79 A 25278 D Common Stock 2023-06-14 4 S 0 1601 192.0613 D 23677 D Common Stock 2023-06-14 4 M 0 2104 58.79 A 25781 D Common Stock 2023-06-14 4 M 0 2418 58.79 A 28199 D Common Stock 2023-06-14 4 S 0 2418 194.0219 D 25781 D Common Stock 2023-06-14 4 M 0 100 58.79 A 25881 D Common Stock 2023-06-14 4 S 0 100 194.73 D 25781 D Common Stock 2023-06-14 4 S 0 2104 193.296 D 23677 D Common Stock 60000 I by Trust Non-Qualified Stock Option (right to buy) 58.79 2023-06-14 4 M 0 6712 0.0 D 2018-02-13 2024-02-24 Common Stock 6712 199654 D Non-Qualified Stock Option (right to buy) 58.79 2023-06-14 4 M 0 3637 0.0 D 2018-02-13 2024-02-24 Common Stock 3637 196017 D Non-Qualified Stock Option (right to buy) 58.79 2023-06-14 4 M 0 2781 0.0 D 2018-02-13 2024-02-24 Common Stock 2781 193236 D Non-Qualified Stock Option (right to buy) 58.79 2023-06-14 4 M 0 8163 0.0 D 2018-02-13 2024-02-24 Common Stock 8163 185073 D Non-Qualified Stock Option (right to buy) 58.79 2023-06-14 4 M 0 785 0.0 D 2018-02-13 2024-02-24 Common Stock 785 184288 D Non-Qualified Stock Option (right to buy) 58.79 2023-06-14 4 M 0 1699 0.0 D 2018-02-13 2024-02-24 Common Stock 1699 182589 D Non-Qualified Stock Option (right to buy) 58.79 2023-06-14 4 M 0 1601 0.0 D 2018-02-13 2024-02-24 Common Stock 1601 180988 D Non-Qualified Stock Option (right to buy) 58.79 2023-06-14 4 M 0 2104 0.0 D 2018-02-13 2024-02-24 Common Stock 2104 178884 D Non-Qualified Stock Option (right to buy) 58.79 2023-06-14 4 M 0 2418 0.0 D 2018-02-13 2024-02-24 Common Stock 2418 176466 D Non-Qualified Stock Option (right to buy) 58.79 2023-06-14 4 M 0 100 0.0 D 2018-02-13 2024-02-24 Common Stock 100 176366 D The option exercises/sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 15, 2023. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $185.04 to $186.03, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $186.05 to $187.04, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $187.05 to $188.03, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $188.06 to $189.03, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $189.06 to $189.89, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $190.16 to $191.12, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $191.44 to $192.385, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $193.58 to $194.21, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. All shares sold were sold at the exact price disclosed. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $192.52 to $193.515, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. This transaction represented a gift of securities from the reporting person to two trusts for the benefit of family members, who share the same household. The reporting person disclaims beneficial ownership of the shares held by the trusts, and this report shall not be deemed as an admission that the reporting person is the beneficial owner of the trust's shares for purposes of Section 16 or for any other purpose. Vivek Jain 2023-06-15